Salarius Pharmaceuticals Files 8-K
Ticker: DCOY · Form: 8-K · Filed: Jul 29, 2025 · CIK: 1615219
Sentiment: neutral
Topics: material-agreement, corporate-action, financial-reporting
TL;DR
Salarius Pharma dropped an 8-K on 7/29, watch for material agreements & financial updates.
AI Summary
Salarius Pharmaceuticals, Inc. filed an 8-K on July 29, 2025, reporting on material definitive agreements and modifications to security holder rights. The filing also includes financial statements and exhibits. The company, formerly known as Flex Pharma, Inc., is based in Houston, TX.
Why It Matters
This 8-K filing indicates significant corporate actions and financial reporting by Salarius Pharmaceuticals, Inc., which could impact investors and stakeholders.
Risk Assessment
Risk Level: medium — 8-K filings often contain material information that can significantly impact a company's stock price and investor outlook.
Key Numbers
- 001-36812 — SEC File Number (Identifies the company's filing with the SEC.)
- 46-5087339 — IRS Employer Identification Number (Company's tax identification number.)
Key Players & Entities
- Salarius Pharmaceuticals, Inc. (company) — Registrant
- July 29, 2025 (date) — Date of earliest event reported
- Flex Pharma, Inc. (company) — Former company name
- Houston, TX (location) — Principal executive offices
FAQ
What specific material definitive agreements were entered into by Salarius Pharmaceuticals, Inc. on or before July 29, 2025?
The filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in this excerpt.
What modifications to the rights of security holders are reported in this 8-K?
The filing notes 'Material Modifications to Rights of Security Holders' as an item information, but the specifics are not detailed in the provided text.
What financial statements and exhibits are included with this 8-K filing?
The filing lists 'Financial Statements and Exhibits' as an item information, but the content of these documents is not described in the excerpt.
When did Salarius Pharmaceuticals, Inc. change its name from Flex Pharma, Inc.?
The date of the name change from Flex Pharma, Inc. to Salarius Pharmaceuticals, Inc. was July 30, 2014.
What is the principal business address of Salarius Pharmaceuticals, Inc.?
The principal executive offices are located at 2450 Holcombe Blvd. Suite X, Houston, TX 77021.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 29, 2025 regarding Salarius Pharmaceuticals, Inc. (DCOY).